细胞外矩阵的重新正常化,以改善瘤病毒的冷瘤透
Geofrey F Soko1,2, Benson K Kosgei1, Stephene S Meena1,2
1Jiangzhong Cancer Research Center, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China & Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine, Nanchang, China.
Frontiers in immunology
|January 23, 2025
概括
瘤病毒 (OV) 难以透瘤,限制了免疫治疗的有效性. 正在制定克服物理障碍的策略,以改善OV输送和增强冷瘤中的抗瘤免疫反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 免疫疗法面临着免疫无效 (冷) 瘤的挑战.
- 瘤病毒 (OV) 诱导免疫细胞死亡 (ICD),以启动癌症免疫循环 (CIC) 和CD8+ T细胞透.
- 由于OV的透和分布有限,OV免疫疗法 (OVI) 的临床结果往往不足.
研究的目的:
- 调查阻碍有效型病毒免疫治疗 (OVI) 的障碍.
- 探索增强OV内透和分布的策略.
- 审查转化OVI策略对感冒瘤的进展和临床挑战.
主要方法:
- 对冷瘤中OV限制现有文献的综述.
- 分析癌症相关纤维细胞 (CAF) 和细胞外基质 (ECM) 在阻碍OV输送中的作用.
- 研究改善OV透和随后的T细胞透的新策略.
主要成果:
- 限制OVs的内透和分布是低于最佳OVI反应的关键因素.
- 瘤细胞外基质 (ECM) 脱质形成和间位液压 (IFP) 的升高会产生物理障碍.
- 进展侧重于克服这些障碍,以促进OV和瘤透淋巴细胞 (TIL) 输送.
结论:
- 克服冷瘤内的物理障碍对于有效的OVI至关重要.
- 提高OV透率的策略有望改善免疫治疗结果.
- 需要进一步的研究和临床翻译,以优化OVI对具有挑战性的瘤微环境.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
467
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
467
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


